Cell-Sized Lipid Vesicles as Artificial Antigen-Presenting Cells for Antigen-Specific T Cell Activation

Adv Healthc Mater. 2023 May;12(12):e2203163. doi: 10.1002/adhm.202203163. Epub 2023 Jan 31.

Abstract

In this study, efficient T cell activation is demonstrated using cell-sized artificial antigen-presenting cells (aAPCs) with protein-conjugated bilayer lipid membranes that mimic biological cell membranes. The highly uniform aAPCs are generated by a facile method based on standard droplet microfluidic devices. These aAPCs are able to activate the T cells in peripheral blood mononuclear cells, showing a 28-fold increase in interferon gamma (IFNγ) secretion, a 233-fold increase in antigen-specific CD8 T cells expansion, and a 16-fold increase of CD4 T cell expansion. The aAPCs do not require repetitive boosting or additional stimulants and can function at a relatively low aAPC-to-T cell ratio (1:17). The research presents strong evidence that the surface fluidity and size of the aAPCs are critical to the effective formation of immune synapses essential for T cell activation. The findings demonstrate that the microfluidic-generated aAPCs can be instrumental in investigating the physiological conditions and mechanisms for T cell activation. Finally, this method demonstrates the feasibility of customizable aAPCs for a cost-effective off-the-shelf approach to immunotherapy.

Keywords: T cell activation; artificial antigen-presenting cells; droplet generation; immunotherapy; microfluidics.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antigen-Presenting Cells*
  • Immunotherapy / methods
  • Leukocytes, Mononuclear*
  • Lipids
  • Lymphocyte Activation

Substances

  • Lipids